Company overview
Basic information
Company name
SmartPharma Group, UAB
Company code
305372502
VAT code
LT100013095919
Registered address
Vilnius, Žalgirio g. 90-100, LT-09303
Registration date
2019-12-03
Company age: 6 y. 10 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
None
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Business and other management consultancy activities
Sector
Užsienio subjektų kontroliuojamos ne finansų bendrovės
Ownership form
Private foreign capital
SmartPharma Group, UAB
Company code: 305372502
Address: Vilnius, Žalgirio g. 90-100, LT-09303
VAT code: LT100013095919
Description
This description was generated by artificial intelligence.
SmartPharma Group, UAB (company code 305372502) is an operational private limited liability company registered in 2019. It is a micro-sized private company controlled by foreign entities, with private ownership in which foreign natural and legal persons hold more than 50% of the authorised capital. The company is governed by a CEO only. Its registered address is Žalgirio g. 90-100, Vilnius, Vilniaus m. sav., Vilniaus apskr.
The company’s main activity is Business and other management consultancy activities (EVRK code N.70.20.00). Its share capital is €2.5K. In financial year 2025, revenue amounted to €680.1K, compared with €858.7K in 2024 and €446.0K in 2023. Net profit was €141.0K in 2025, after €273.4K in 2024 and €22.2K in 2023, with a 20.7% profit margin in the latest year. Equity stood at €480.1K and total assets at €684.4K in 2025, while liabilities were €205.4K. The latest staff data show an average of 2 employees so far in 2026, up from 1 employee in 2023 and 2024.
The company’s main activity is Business and other management consultancy activities (EVRK code N.70.20.00). Its share capital is €2.5K. In financial year 2025, revenue amounted to €680.1K, compared with €858.7K in 2024 and €446.0K in 2023. Net profit was €141.0K in 2025, after €273.4K in 2024 and €22.2K in 2023, with a 20.7% profit margin in the latest year. Equity stood at €480.1K and total assets at €684.4K in 2025, while liabilities were €205.4K. The latest staff data show an average of 2 employees so far in 2026, up from 1 employee in 2023 and 2024.
Download a detailed company report
Make confident decisions with all the information about SmartPharma Group, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.